GREENBROOK TMS RECEIVES NASDAQ DELISTING NOTICE AND INTENDS TO APPEAL

$GBNH
Misc Health and Biotechnology Services
Health Care
Get the next $GBNH alert in real time by email

Weekly insight reads limit reached.

Join Quantisnow to enjoy unlimited reads, alerts, live feeds, and more.

Meet Quantisnow

Stock alerts. Live news feeds. Press releases. Insider trading. FDA approvals & more.

Invest smarter

A better trading workflow

Access market-moving news before they break out to the general public. Let Quantisnow cut out the noise and only receive insights that matter.

Live feeds
Real-time news feeds for Press Releases, SEC Filings, FDA approvals, market insights and more.
Custom filters
Filter out the noise with company filters, market cap filters, price filters and more.
Audio Squawk
Multitask with confidence and let Quantsinow read breaking news out loud.
Product screenshot
Quantisnow AI Features

Save time

Unlock Insights with AI

Get quick summaries and precise Q&A for every insight, empowering you to make informed decisions without sifting through entire press releases and lengthy SEC filings.

Get alerted immediately

All your stock market alerts in one place

Quantisnow alerts are fast, customizable, and versatile.

Email alerts
Subscribe to your favorite stocks and receive email alerts each time a news pops up.
App notifications
Reduce alerting latency with in-app notifications. Same as email alerts, but faster.
Webhooks
Integrate with Quantisnow programmatically and receive live insights via webhooks
Granular alerts
Want to receive Press Releases but no SEC filings? No problem - Quantisnow alerts are highly customizable and can seemlessly tailor to your trading needs.

Elevate your trading.
Start using Quantisnow today.

Never miss an update.

App screenshot

Simple no-tricks pricing

One membership with full access and no delays.

Quantisnow Plus

Your personal trading assistant for just $39/month.

What's included

  • Live feeds
  • Audio squawk
  • Compact mode in feeds
  • Email alerts
  • App push alerts
  • Unlimited insights reads
  • Unlimited subscriptions
  • Advanced filters in live feeds
  • Support
  • No ads
  • AI-generated summaries and Q&A

One membership - all access

$39/month

Get access

$39/month with yearly billing, $49/month with monthly billing

News insights ingested and delivered in real time
5 million+
Real-time news alerts sent out to Quantisnow users
700,000+
Latency of news delivery pipelines to users via mobile app, webhooks, and email
<100ms
Get the next $GBNH alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$GBNH

DatePrice TargetRatingAnalyst
More analyst ratings

$GBNH
Press Releases

Fastest customizable press release news feed in the world

See more
  • Greybrook Announces Passing of Founder Elias Vamvakas

    TORONTO, July 11, 2024 /CNW/ - It is with heavy hearts that the Executive Team at Greybrook announces the passing of our cherished founder, Elias Vamvakas, today, after a courageous battle with pancreatic cancer. Elias was 65 years old. Elias Vamvakas was a visionary leader whose entrepreneurial spirit and dedication laid the foundation for Greybrook, a distinguished Canadian private equity firm with investments in real estate and health care. Born in 1958 in Athens, Greece, Elias immigrated to Canada in 1966. His journey from an immigrant to a celebrated business leader was a

    $GBNH
    Misc Health and Biotechnology Services
    Health Care
  • GREENBROOK TMS ANNOUNCES DELISTING FROM NASDAQ

    TORONTO, Feb. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced receipt of the final delisting notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") due to the continued failure to satisfy either the $1.00 minimum bid price listing requirement in Nasdaq Listing Rule 5550(a)(2) or the minimum stockholders' equity requirements in Nasdaq Listing Rule 5550(b). Nasdaq has notified the Company that trading of its common shares (the "Common Shares") will be suspended as of the open of trading on February 26, 2024. After careful consideration, the Company determined that it was in the overall best interests

    $GBNH
    Misc Health and Biotechnology Services
    Health Care
  • Greenbrook Announces $1.2 Million Registered Direct Offering

    TORONTO, Feb. 22, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company"), today announced that it has entered into securities purchase agreements with  institutional investors for the purchase and sale of 6,000,000 common shares at a purchase price of $0.20 per share pursuant to a registered direct offering, resulting in gross proceeds of approximately $1.2 million before deducting placement agent commissions and other estimated offering expenses. The closing of the offering is expected to occur on or about February 26, 2024, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds for working capital as well as

    $GBNH
    Misc Health and Biotechnology Services
    Health Care

$GBNH
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$GBNH
SEC Filings

See more

$GBNH
Leadership Updates

Live Leadership Updates

See more
  • GREENBROOK APPOINTS PETER WILLETT AS CHIEF FINANCIAL OFFICER

    TORONTO, Jan. 29, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that the Company's Board of Directors has appointed Mr. Peter Willett as the Company's full-time Chief Financial Officer, effective immediately. Mr. Willett was appointed Interim Chief Financial Officer of the Company in October 2023, prior to which he has been a key player on the Greenbrook finance team over the past six years, serving as its Senior Vice President of Finance. Peter brings over 11 years of finance experience, providing a broad base of experience and specialized knowledge about the financial and accounting matters that are unique to the mental health servic

    $GBNH
    Misc Health and Biotechnology Services
    Health Care
  • GREENBROOK TMS ANNOUNCES DIRECTOR APPOINTMENT

    TORONTO, Jan. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has appointed Ms. Juliana Elstad to the Company's board of directors as an independent director, effective immediately. Ms. Elstad has also been appointed to the Company's Governance and Nominating Committee. Juliana Elstad is a CEO, entrepreneur, and advisor with over 20 years of experience bringing medical innovation to patients and delivering success in small startup to multi-billion-dollar environments. She has a proven track record of creating, growing, and leading medical technology organizations with a focus on building dynamic cultures and mentoring high-po

    $GBNH
    Misc Health and Biotechnology Services
    Health Care
  • GREENBROOK TMS ANNOUNCES RESULTS OF VOTING AT ANNUAL MEETING OF SHAREHOLDERS

    TORONTO, June 20, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United States, announced today the results of voting at its annual meeting of shareholders held earlier today (the "Meeting"). Each of the matters voted upon at the Meeting as set out below is described in greater detail in the Notice of Annual Meeting of Shareholders and Management Information Circular of Greenbrook dated May 11, 2023 (the "Circular").   The total number of common shares represented at the Meeting was 29,769,721, representing approximately 72.96% of Greenbrook's outstanding common shares entit

    $GBNH
    Misc Health and Biotechnology Services
    Health Care

$GBNH
Financials

Live finance-specific insights

See more
  • GREENBROOK TMS ANNOUNCES DELISTING FROM NASDAQ

    TORONTO, Feb. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced receipt of the final delisting notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") due to the continued failure to satisfy either the $1.00 minimum bid price listing requirement in Nasdaq Listing Rule 5550(a)(2) or the minimum stockholders' equity requirements in Nasdaq Listing Rule 5550(b). Nasdaq has notified the Company that trading of its common shares (the "Common Shares") will be suspended as of the open of trading on February 26, 2024. After careful consideration, the Company determined that it was in the overall best interests

    $GBNH
    Misc Health and Biotechnology Services
    Health Care
  • GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING

    TORONTO, Feb. 15, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-fifth amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$2,538,071 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$87 million outstanding under the Credit Facility. The proceeds of the New Loan are expected to be used by the Company for general corporate an

    $GBNH
    Misc Health and Biotechnology Services
    Health Care
  • GREENBROOK TMS RAISES US$1.5 MILLION IN DEBT FINANCING

    TORONTO, Feb. 6, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-fourth amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$1,522,843 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$85 million outstanding under the Credit Facility. The proceeds of the New Loan are expected to be used by the Company for general corporate an

    $GBNH
    Misc Health and Biotechnology Services
    Health Care

$GBNH
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more